FDA inspection

Shilpa Medicare Limited: FDA inspection ending Sep 6, 2019

FDA inspection 1101543 · Voluntary Action Indicated (VAI) · Jadcherla, Mahabubnagar District

Key facts

Inspection ID 1101543
Firm Shilpa Medicare Limited
FEI number 3009876430
Address S-20 To S-26, Pharm. Formulation Sez, Tsiic, Green Industrial Park
City Jadcherla, Mahabubnagar District
Country India
Fiscal year 2019
Inspection end date Sep 6, 2019
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections